nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Ethinyl Estradiol—osteoporosis	0.324	0.437	CbGbCtD
Clofazimine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0555	0.075	CbGbCtD
Clofazimine—CYP3A4—Estropipate—osteoporosis	0.0516	0.0697	CbGbCtD
Clofazimine—CYP3A4—Calcitriol—osteoporosis	0.0516	0.0697	CbGbCtD
Clofazimine—CYP3A4—Ergocalciferol—osteoporosis	0.0412	0.0557	CbGbCtD
Clofazimine—ABCB1—Conjugated Estrogens—osteoporosis	0.0407	0.055	CbGbCtD
Clofazimine—ABCB1—Estradiol—osteoporosis	0.0358	0.0483	CbGbCtD
Clofazimine—CYP3A4—Raloxifene—osteoporosis	0.0344	0.0465	CbGbCtD
Clofazimine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0332	0.0449	CbGbCtD
Clofazimine—CYP3A4—Cholecalciferol—osteoporosis	0.0266	0.0359	CbGbCtD
Clofazimine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0244	0.033	CbGbCtD
Clofazimine—CYP3A4—Estradiol—osteoporosis	0.0214	0.0289	CbGbCtD
Clofazimine—ABCB11—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00779	0.262	CbGpPWpGaD
Clofazimine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00278	0.0938	CbGpPWpGaD
Clofazimine—Embolism venous—Conjugated Estrogens—osteoporosis	0.00262	0.0114	CcSEcCtD
Clofazimine—Embolism—Ethinyl Estradiol—osteoporosis	0.00253	0.011	CcSEcCtD
Clofazimine—Bone pain—Etidronic acid—osteoporosis	0.00242	0.0105	CcSEcCtD
Clofazimine—Neuralgia—Risedronate—osteoporosis	0.00228	0.0099	CcSEcCtD
Clofazimine—Embolism venous—Estradiol—osteoporosis	0.0021	0.00912	CcSEcCtD
Clofazimine—Embolism—Conjugated Estrogens—osteoporosis	0.00206	0.00896	CcSEcCtD
Clofazimine—ABCB11—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—CYP27A1—osteoporosis	0.00206	0.0693	CbGpPWpGaD
Clofazimine—Bone pain—Ibandronate—osteoporosis	0.002	0.00871	CcSEcCtD
Clofazimine—Bone pain—Calcitriol—osteoporosis	0.00196	0.00853	CcSEcCtD
Clofazimine—Cystitis noninfective—Estropipate—osteoporosis	0.00196	0.0085	CcSEcCtD
Clofazimine—Intestinal obstruction—Conjugated Estrogens—osteoporosis	0.00194	0.00843	CcSEcCtD
Clofazimine—Cystitis—Estropipate—osteoporosis	0.00193	0.0084	CcSEcCtD
Clofazimine—Cystitis noninfective—Raloxifene—osteoporosis	0.00189	0.00823	CcSEcCtD
Clofazimine—Cystitis noninfective—Ibandronate—osteoporosis	0.00188	0.00815	CcSEcCtD
Clofazimine—Cystitis—Raloxifene—osteoporosis	0.00187	0.00814	CcSEcCtD
Clofazimine—ABCB11—Synthesis of bile acids and bile salts—CYP27A1—osteoporosis	0.00187	0.0631	CbGpPWpGaD
Clofazimine—Cystitis—Ibandronate—osteoporosis	0.00185	0.00806	CcSEcCtD
Clofazimine—Bladder pain—Estropipate—osteoporosis	0.00181	0.00787	CcSEcCtD
Clofazimine—Weight decreased—Ergocalciferol—osteoporosis	0.00177	0.00768	CcSEcCtD
Clofazimine—Bladder pain—Raloxifene—osteoporosis	0.00175	0.00762	CcSEcCtD
Clofazimine—Bladder pain—Ibandronate—osteoporosis	0.00174	0.00754	CcSEcCtD
Clofazimine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00172	0.0578	CbGpPWpGaD
Clofazimine—Bone pain—Risedronate—osteoporosis	0.00165	0.00718	CcSEcCtD
Clofazimine—Embolism—Estradiol—osteoporosis	0.00165	0.00717	CcSEcCtD
Clofazimine—Cystitis noninfective—Ethinyl Estradiol—osteoporosis	0.00159	0.00689	CcSEcCtD
Clofazimine—Bone pain—Pamidronate—osteoporosis	0.00157	0.00682	CcSEcCtD
Clofazimine—Cystitis—Ethinyl Estradiol—osteoporosis	0.00157	0.00681	CcSEcCtD
Clofazimine—Intestinal obstruction—Estradiol—osteoporosis	0.00155	0.00675	CcSEcCtD
Clofazimine—Cystitis noninfective—Risedronate—osteoporosis	0.00155	0.00672	CcSEcCtD
Clofazimine—Cystitis—Risedronate—osteoporosis	0.00153	0.00664	CcSEcCtD
Clofazimine—ABCB11—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00149	0.0501	CbGpPWpGaD
Clofazimine—Bladder pain—Ethinyl Estradiol—osteoporosis	0.00147	0.00638	CcSEcCtD
Clofazimine—Bone pain—Zoledronate—osteoporosis	0.00143	0.00623	CcSEcCtD
Clofazimine—Bladder pain—Risedronate—osteoporosis	0.00143	0.00622	CcSEcCtD
Clofazimine—Cystitis noninfective—Conjugated Estrogens—osteoporosis	0.00129	0.00562	CcSEcCtD
Clofazimine—Cystitis—Conjugated Estrogens—osteoporosis	0.00128	0.00555	CcSEcCtD
Clofazimine—Abdominal pain upper—Ibandronate—osteoporosis	0.00127	0.00553	CcSEcCtD
Clofazimine—Anaemia—Ergocalciferol—osteoporosis	0.00126	0.00547	CcSEcCtD
Clofazimine—Oedema—Calcium Acetate—osteoporosis	0.00126	0.00547	CcSEcCtD
Clofazimine—Abdominal pain upper—Calcitriol—osteoporosis	0.00125	0.00542	CcSEcCtD
Clofazimine—ABCB11—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00124	0.0419	CbGpPWpGaD
Clofazimine—Anorexia—Calcium Acetate—osteoporosis	0.0012	0.00521	CcSEcCtD
Clofazimine—Bladder pain—Conjugated Estrogens—osteoporosis	0.0012	0.0052	CcSEcCtD
Clofazimine—Skin discolouration—Estradiol—osteoporosis	0.00117	0.00509	CcSEcCtD
Clofazimine—Hyperglycaemia—Estropipate—osteoporosis	0.00113	0.00492	CcSEcCtD
Clofazimine—Photosensitivity reaction—Alendronate—osteoporosis	0.00113	0.00491	CcSEcCtD
Clofazimine—Depression—Estropipate—osteoporosis	0.00112	0.00485	CcSEcCtD
Clofazimine—Bone pain—Estradiol—osteoporosis	0.00111	0.0048	CcSEcCtD
Clofazimine—Decreased appetite—Calcium Acetate—osteoporosis	0.00109	0.00475	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.00109	0.00475	CcSEcCtD
Clofazimine—Weight decreased—Ibandronate—osteoporosis	0.00109	0.00474	CcSEcCtD
Clofazimine—Depression—Raloxifene—osteoporosis	0.00108	0.0047	CcSEcCtD
Clofazimine—Constipation—Calcium Acetate—osteoporosis	0.00108	0.00467	CcSEcCtD
Clofazimine—Depression—Ibandronate—osteoporosis	0.00107	0.00465	CcSEcCtD
Clofazimine—Weight decreased—Calcitriol—osteoporosis	0.00107	0.00464	CcSEcCtD
Clofazimine—Anorexia—Ergocalciferol—osteoporosis	0.00106	0.0046	CcSEcCtD
Clofazimine—Drowsiness—Calcitriol—osteoporosis	0.00105	0.00457	CcSEcCtD
Clofazimine—Abdominal pain upper—Risedronate—osteoporosis	0.00105	0.00456	CcSEcCtD
Clofazimine—Cystitis noninfective—Estradiol—osteoporosis	0.00103	0.00449	CcSEcCtD
Clofazimine—Cystitis—Estradiol—osteoporosis	0.00102	0.00444	CcSEcCtD
Clofazimine—Hypokalaemia—Pamidronate—osteoporosis	0.000994	0.00432	CcSEcCtD
Clofazimine—Visual impairment—Estropipate—osteoporosis	0.000969	0.00421	CcSEcCtD
Clofazimine—Decreased appetite—Ergocalciferol—osteoporosis	0.000966	0.0042	CcSEcCtD
Clofazimine—Bladder pain—Estradiol—osteoporosis	0.000958	0.00416	CcSEcCtD
Clofazimine—Constipation—Ergocalciferol—osteoporosis	0.00095	0.00413	CcSEcCtD
Clofazimine—Anaemia—Etidronic acid—osteoporosis	0.000935	0.00406	CcSEcCtD
Clofazimine—ABCB11—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000931	0.0314	CbGpPWpGaD
Clofazimine—Weight decreased—Ethinyl Estradiol—osteoporosis	0.000921	0.004	CcSEcCtD
Clofazimine—Abdominal pain upper—Zoledronate—osteoporosis	0.000911	0.00396	CcSEcCtD
Clofazimine—Hypokalaemia—Zoledronate—osteoporosis	0.000908	0.00394	CcSEcCtD
Clofazimine—Depression—Ethinyl Estradiol—osteoporosis	0.000905	0.00393	CcSEcCtD
Clofazimine—Asthenia—Calcium Acetate—osteoporosis	0.000903	0.00392	CcSEcCtD
Clofazimine—Lymphadenopathy—Estradiol—osteoporosis	0.000901	0.00392	CcSEcCtD
Clofazimine—Pruritus—Calcium Acetate—osteoporosis	0.00089	0.00387	CcSEcCtD
Clofazimine—Depression—Risedronate—osteoporosis	0.000883	0.00384	CcSEcCtD
Clofazimine—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.000874	0.0038	CcSEcCtD
Clofazimine—Diarrhoea—Calcium Acetate—osteoporosis	0.000861	0.00374	CcSEcCtD
Clofazimine—Dizziness—Calcium Acetate—osteoporosis	0.000832	0.00361	CcSEcCtD
Clofazimine—Vomiting—Calcium Acetate—osteoporosis	0.0008	0.00348	CcSEcCtD
Clofazimine—Asthenia—Ergocalciferol—osteoporosis	0.000797	0.00346	CcSEcCtD
Clofazimine—Anaemia—Alendronate—osteoporosis	0.000797	0.00346	CcSEcCtD
Clofazimine—Visual impairment—Ethinyl Estradiol—osteoporosis	0.000786	0.00341	CcSEcCtD
Clofazimine—Weight decreased—Zoledronate—osteoporosis	0.00078	0.00339	CcSEcCtD
Clofazimine—Anaemia—Ibandronate—osteoporosis	0.000776	0.00337	CcSEcCtD
Clofazimine—Depression—Zoledronate—osteoporosis	0.000767	0.00333	CcSEcCtD
Clofazimine—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000749	0.00325	CcSEcCtD
Clofazimine—Nausea—Calcium Acetate—osteoporosis	0.000747	0.00325	CcSEcCtD
Clofazimine—Depression—Conjugated Estrogens—osteoporosis	0.000738	0.00321	CcSEcCtD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000715	0.0241	CbGpPWpGaD
Clofazimine—Oedema—Estropipate—osteoporosis	0.000714	0.0031	CcSEcCtD
Clofazimine—Constipation—Etidronic acid—osteoporosis	0.000706	0.00307	CcSEcCtD
Clofazimine—Abdominal pain upper—Estradiol—osteoporosis	0.000702	0.00305	CcSEcCtD
Clofazimine—Nausea—Ergocalciferol—osteoporosis	0.00066	0.00287	CcSEcCtD
Clofazimine—Visual impairment—Conjugated Estrogens—osteoporosis	0.00064	0.00278	CcSEcCtD
Clofazimine—Anaemia—Risedronate—osteoporosis	0.000639	0.00278	CcSEcCtD
Clofazimine—Anorexia—Calcitriol—osteoporosis	0.000639	0.00278	CcSEcCtD
Clofazimine—Somnolence—Estropipate—osteoporosis	0.000635	0.00276	CcSEcCtD
Clofazimine—Fatigue—Estropipate—osteoporosis	0.000616	0.00268	CcSEcCtD
Clofazimine—Constipation—Estropipate—osteoporosis	0.000611	0.00265	CcSEcCtD
Clofazimine—Anaemia—Pamidronate—osteoporosis	0.000608	0.00264	CcSEcCtD
Clofazimine—Photosensitivity reaction—Estradiol—osteoporosis	0.000606	0.00264	CcSEcCtD
Clofazimine—Constipation—Alendronate—osteoporosis	0.000602	0.00261	CcSEcCtD
Clofazimine—Weight decreased—Estradiol—osteoporosis	0.000601	0.00261	CcSEcCtD
Clofazimine—Hyperglycaemia—Estradiol—osteoporosis	0.000599	0.0026	CcSEcCtD
Clofazimine—Somnolence—Calcitriol—osteoporosis	0.000596	0.00259	CcSEcCtD
Clofazimine—Decreased appetite—Ibandronate—osteoporosis	0.000596	0.00259	CcSEcCtD
Clofazimine—Depression—Estradiol—osteoporosis	0.000591	0.00257	CcSEcCtD
Clofazimine—Fatigue—Ibandronate—osteoporosis	0.000591	0.00257	CcSEcCtD
Clofazimine—Constipation—Ibandronate—osteoporosis	0.000586	0.00255	CcSEcCtD
Clofazimine—Pruritus—Etidronic acid—osteoporosis	0.000584	0.00254	CcSEcCtD
Clofazimine—Decreased appetite—Calcitriol—osteoporosis	0.000583	0.00253	CcSEcCtD
Clofazimine—Oedema—Ethinyl Estradiol—osteoporosis	0.000579	0.00252	CcSEcCtD
Clofazimine—Jaundice—Estradiol—osteoporosis	0.000577	0.00251	CcSEcCtD
Clofazimine—Constipation—Calcitriol—osteoporosis	0.000574	0.00249	CcSEcCtD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.00057	0.0192	CbGpPWpGaD
Clofazimine—Diarrhoea—Etidronic acid—osteoporosis	0.000565	0.00246	CcSEcCtD
Clofazimine—Body temperature increased—Estropipate—osteoporosis	0.000565	0.00245	CcSEcCtD
Clofazimine—Body temperature increased—Alendronate—osteoporosis	0.000556	0.00242	CcSEcCtD
Clofazimine—Anaemia—Zoledronate—osteoporosis	0.000555	0.00241	CcSEcCtD
Clofazimine—Body temperature increased—Raloxifene—osteoporosis	0.000547	0.00238	CcSEcCtD
Clofazimine—Body temperature increased—Ibandronate—osteoporosis	0.000542	0.00235	CcSEcCtD
Clofazimine—Oedema—Pamidronate—osteoporosis	0.000537	0.00233	CcSEcCtD
Clofazimine—Hepatitis—Estradiol—osteoporosis	0.000532	0.00231	CcSEcCtD
Clofazimine—Body temperature increased—Calcitriol—osteoporosis	0.00053	0.0023	CcSEcCtD
Clofazimine—Vomiting—Etidronic acid—osteoporosis	0.000525	0.00228	CcSEcCtD
Clofazimine—Rash—Etidronic acid—osteoporosis	0.000521	0.00226	CcSEcCtD
Clofazimine—Dermatitis—Etidronic acid—osteoporosis	0.00052	0.00226	CcSEcCtD
Clofazimine—Headache—Etidronic acid—osteoporosis	0.000517	0.00225	CcSEcCtD
Clofazimine—Asthenia—Estropipate—osteoporosis	0.000513	0.00223	CcSEcCtD
Clofazimine—Visual impairment—Estradiol—osteoporosis	0.000513	0.00223	CcSEcCtD
Clofazimine—Anorexia—Pamidronate—osteoporosis	0.000512	0.00222	CcSEcCtD
Clofazimine—Pruritus—Estropipate—osteoporosis	0.000506	0.0022	CcSEcCtD
Clofazimine—Asthenia—Alendronate—osteoporosis	0.000505	0.00219	CcSEcCtD
Clofazimine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000499	0.00217	CcSEcCtD
Clofazimine—Pruritus—Alendronate—osteoporosis	0.000498	0.00216	CcSEcCtD
Clofazimine—Constipation—Ethinyl Estradiol—osteoporosis	0.000495	0.00215	CcSEcCtD
Clofazimine—Asthenia—Ibandronate—osteoporosis	0.000492	0.00214	CcSEcCtD
Clofazimine—Nausea—Etidronic acid—osteoporosis	0.000491	0.00213	CcSEcCtD
Clofazimine—Oedema—Zoledronate—osteoporosis	0.00049	0.00213	CcSEcCtD
Clofazimine—Diarrhoea—Estropipate—osteoporosis	0.000489	0.00212	CcSEcCtD
Clofazimine—Fatigue—Risedronate—osteoporosis	0.000487	0.00212	CcSEcCtD
Clofazimine—Pruritus—Ibandronate—osteoporosis	0.000485	0.00211	CcSEcCtD
Clofazimine—Constipation—Risedronate—osteoporosis	0.000483	0.0021	CcSEcCtD
Clofazimine—Diarrhoea—Alendronate—osteoporosis	0.000482	0.00209	CcSEcCtD
Clofazimine—Asthenia—Calcitriol—osteoporosis	0.000481	0.00209	CcSEcCtD
Clofazimine—Somnolence—Pamidronate—osteoporosis	0.000477	0.00207	CcSEcCtD
Clofazimine—Pruritus—Calcitriol—osteoporosis	0.000475	0.00206	CcSEcCtD
Clofazimine—Diarrhoea—Raloxifene—osteoporosis	0.000474	0.00206	CcSEcCtD
Clofazimine—Dizziness—Estropipate—osteoporosis	0.000472	0.00205	CcSEcCtD
Clofazimine—Oedema—Conjugated Estrogens—osteoporosis	0.000472	0.00205	CcSEcCtD
Clofazimine—Diarrhoea—Ibandronate—osteoporosis	0.000469	0.00204	CcSEcCtD
Clofazimine—Anorexia—Zoledronate—osteoporosis	0.000467	0.00203	CcSEcCtD
Clofazimine—Decreased appetite—Pamidronate—osteoporosis	0.000467	0.00203	CcSEcCtD
Clofazimine—Dizziness—Alendronate—osteoporosis	0.000465	0.00202	CcSEcCtD
Clofazimine—Fatigue—Pamidronate—osteoporosis	0.000463	0.00201	CcSEcCtD
Clofazimine—Constipation—Pamidronate—osteoporosis	0.000459	0.00199	CcSEcCtD
Clofazimine—Diarrhoea—Calcitriol—osteoporosis	0.000459	0.00199	CcSEcCtD
Clofazimine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000458	0.00199	CcSEcCtD
Clofazimine—Dizziness—Raloxifene—osteoporosis	0.000458	0.00199	CcSEcCtD
Clofazimine—Vomiting—Estropipate—osteoporosis	0.000454	0.00197	CcSEcCtD
Clofazimine—Dizziness—Ibandronate—osteoporosis	0.000453	0.00197	CcSEcCtD
Clofazimine—Rash—Estropipate—osteoporosis	0.000451	0.00196	CcSEcCtD
Clofazimine—Dermatitis—Estropipate—osteoporosis	0.00045	0.00196	CcSEcCtD
Clofazimine—Anorexia—Conjugated Estrogens—osteoporosis	0.00045	0.00196	CcSEcCtD
Clofazimine—Headache—Estropipate—osteoporosis	0.000448	0.00194	CcSEcCtD
Clofazimine—Vomiting—Alendronate—osteoporosis	0.000447	0.00194	CcSEcCtD
Clofazimine—Body temperature increased—Risedronate—osteoporosis	0.000446	0.00194	CcSEcCtD
Clofazimine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000445	0.015	CbGpPWpGaD
Clofazimine—Rash—Alendronate—osteoporosis	0.000444	0.00193	CcSEcCtD
Clofazimine—Dermatitis—Alendronate—osteoporosis	0.000443	0.00193	CcSEcCtD
Clofazimine—Headache—Alendronate—osteoporosis	0.000441	0.00192	CcSEcCtD
Clofazimine—Vomiting—Raloxifene—osteoporosis	0.00044	0.00191	CcSEcCtD
Clofazimine—Rash—Raloxifene—osteoporosis	0.000436	0.0019	CcSEcCtD
Clofazimine—Dermatitis—Raloxifene—osteoporosis	0.000436	0.00189	CcSEcCtD
Clofazimine—Somnolence—Zoledronate—osteoporosis	0.000436	0.00189	CcSEcCtD
Clofazimine—Vomiting—Ibandronate—osteoporosis	0.000436	0.00189	CcSEcCtD
Clofazimine—Headache—Raloxifene—osteoporosis	0.000434	0.00188	CcSEcCtD
Clofazimine—Rash—Ibandronate—osteoporosis	0.000432	0.00188	CcSEcCtD
Clofazimine—Dermatitis—Ibandronate—osteoporosis	0.000432	0.00188	CcSEcCtD
Clofazimine—Headache—Ibandronate—osteoporosis	0.000429	0.00186	CcSEcCtD
Clofazimine—Vomiting—Calcitriol—osteoporosis	0.000426	0.00185	CcSEcCtD
Clofazimine—Decreased appetite—Zoledronate—osteoporosis	0.000426	0.00185	CcSEcCtD
Clofazimine—Nausea—Estropipate—osteoporosis	0.000424	0.00184	CcSEcCtD
Clofazimine—Body temperature increased—Pamidronate—osteoporosis	0.000424	0.00184	CcSEcCtD
Clofazimine—Rash—Calcitriol—osteoporosis	0.000423	0.00184	CcSEcCtD
Clofazimine—Fatigue—Zoledronate—osteoporosis	0.000423	0.00184	CcSEcCtD
Clofazimine—Dermatitis—Calcitriol—osteoporosis	0.000423	0.00184	CcSEcCtD
Clofazimine—Headache—Calcitriol—osteoporosis	0.00042	0.00183	CcSEcCtD
Clofazimine—Somnolence—Conjugated Estrogens—osteoporosis	0.00042	0.00182	CcSEcCtD
Clofazimine—Constipation—Zoledronate—osteoporosis	0.000419	0.00182	CcSEcCtD
Clofazimine—Nausea—Alendronate—osteoporosis	0.000418	0.00182	CcSEcCtD
Clofazimine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000416	0.00181	CcSEcCtD
Clofazimine—Nausea—Raloxifene—osteoporosis	0.000411	0.00179	CcSEcCtD
Clofazimine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00041	0.00178	CcSEcCtD
Clofazimine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00041	0.00178	CcSEcCtD
Clofazimine—Fatigue—Conjugated Estrogens—osteoporosis	0.000407	0.00177	CcSEcCtD
Clofazimine—Nausea—Ibandronate—osteoporosis	0.000407	0.00177	CcSEcCtD
Clofazimine—Asthenia—Risedronate—osteoporosis	0.000405	0.00176	CcSEcCtD
Clofazimine—Constipation—Conjugated Estrogens—osteoporosis	0.000404	0.00175	CcSEcCtD
Clofazimine—Pruritus—Risedronate—osteoporosis	0.000399	0.00174	CcSEcCtD
Clofazimine—Nausea—Calcitriol—osteoporosis	0.000398	0.00173	CcSEcCtD
Clofazimine—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.000398	0.0134	CbGpPWpGaD
Clofazimine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000396	0.00172	CcSEcCtD
Clofazimine—Body temperature increased—Zoledronate—osteoporosis	0.000388	0.00168	CcSEcCtD
Clofazimine—Diarrhoea—Risedronate—osteoporosis	0.000386	0.00168	CcSEcCtD
Clofazimine—Asthenia—Pamidronate—osteoporosis	0.000385	0.00167	CcSEcCtD
Clofazimine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000383	0.00166	CcSEcCtD
Clofazimine—Pruritus—Pamidronate—osteoporosis	0.00038	0.00165	CcSEcCtD
Clofazimine—Oedema—Estradiol—osteoporosis	0.000378	0.00164	CcSEcCtD
Clofazimine—Dizziness—Risedronate—osteoporosis	0.000373	0.00162	CcSEcCtD
Clofazimine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000373	0.00162	CcSEcCtD
Clofazimine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000368	0.0016	CcSEcCtD
Clofazimine—Diarrhoea—Pamidronate—osteoporosis	0.000367	0.0016	CcSEcCtD
Clofazimine—Rash—Ethinyl Estradiol—osteoporosis	0.000365	0.00159	CcSEcCtD
Clofazimine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000365	0.00159	CcSEcCtD
Clofazimine—Headache—Ethinyl Estradiol—osteoporosis	0.000363	0.00158	CcSEcCtD
Clofazimine—Vomiting—Risedronate—osteoporosis	0.000359	0.00156	CcSEcCtD
Clofazimine—Rash—Risedronate—osteoporosis	0.000356	0.00155	CcSEcCtD
Clofazimine—Dermatitis—Risedronate—osteoporosis	0.000356	0.00155	CcSEcCtD
Clofazimine—Dizziness—Pamidronate—osteoporosis	0.000355	0.00154	CcSEcCtD
Clofazimine—Headache—Risedronate—osteoporosis	0.000354	0.00154	CcSEcCtD
Clofazimine—Asthenia—Zoledronate—osteoporosis	0.000352	0.00153	CcSEcCtD
Clofazimine—Pruritus—Zoledronate—osteoporosis	0.000347	0.00151	CcSEcCtD
Clofazimine—Nausea—Ethinyl Estradiol—osteoporosis	0.000344	0.00149	CcSEcCtD
Clofazimine—Vomiting—Pamidronate—osteoporosis	0.000341	0.00148	CcSEcCtD
Clofazimine—Asthenia—Conjugated Estrogens—osteoporosis	0.000339	0.00147	CcSEcCtD
Clofazimine—Rash—Pamidronate—osteoporosis	0.000338	0.00147	CcSEcCtD
Clofazimine—Dermatitis—Pamidronate—osteoporosis	0.000338	0.00147	CcSEcCtD
Clofazimine—Headache—Pamidronate—osteoporosis	0.000336	0.00146	CcSEcCtD
Clofazimine—Somnolence—Estradiol—osteoporosis	0.000336	0.00146	CcSEcCtD
Clofazimine—Diarrhoea—Zoledronate—osteoporosis	0.000335	0.00146	CcSEcCtD
Clofazimine—Nausea—Risedronate—osteoporosis	0.000335	0.00146	CcSEcCtD
Clofazimine—Pruritus—Conjugated Estrogens—osteoporosis	0.000334	0.00145	CcSEcCtD
Clofazimine—Decreased appetite—Estradiol—osteoporosis	0.000328	0.00143	CcSEcCtD
Clofazimine—Fatigue—Estradiol—osteoporosis	0.000326	0.00142	CcSEcCtD
Clofazimine—Dizziness—Zoledronate—osteoporosis	0.000324	0.00141	CcSEcCtD
Clofazimine—Constipation—Estradiol—osteoporosis	0.000323	0.0014	CcSEcCtD
Clofazimine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000323	0.0014	CcSEcCtD
Clofazimine—Nausea—Pamidronate—osteoporosis	0.000319	0.00139	CcSEcCtD
Clofazimine—Dizziness—Conjugated Estrogens—osteoporosis	0.000312	0.00136	CcSEcCtD
Clofazimine—Vomiting—Zoledronate—osteoporosis	0.000312	0.00135	CcSEcCtD
Clofazimine—Rash—Zoledronate—osteoporosis	0.000309	0.00134	CcSEcCtD
Clofazimine—Dermatitis—Zoledronate—osteoporosis	0.000309	0.00134	CcSEcCtD
Clofazimine—Headache—Zoledronate—osteoporosis	0.000307	0.00133	CcSEcCtD
Clofazimine—Vomiting—Conjugated Estrogens—osteoporosis	0.0003	0.0013	CcSEcCtD
Clofazimine—Body temperature increased—Estradiol—osteoporosis	0.000299	0.0013	CcSEcCtD
Clofazimine—Rash—Conjugated Estrogens—osteoporosis	0.000298	0.00129	CcSEcCtD
Clofazimine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000297	0.00129	CcSEcCtD
Clofazimine—Headache—Conjugated Estrogens—osteoporosis	0.000296	0.00129	CcSEcCtD
Clofazimine—Nausea—Zoledronate—osteoporosis	0.000291	0.00127	CcSEcCtD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000285	0.00959	CbGpPWpGaD
Clofazimine—Nausea—Conjugated Estrogens—osteoporosis	0.00028	0.00122	CcSEcCtD
Clofazimine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000274	0.00923	CbGpPWpGaD
Clofazimine—Asthenia—Estradiol—osteoporosis	0.000271	0.00118	CcSEcCtD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00027	0.00909	CbGpPWpGaD
Clofazimine—Pruritus—Estradiol—osteoporosis	0.000267	0.00116	CcSEcCtD
Clofazimine—Diarrhoea—Estradiol—osteoporosis	0.000259	0.00112	CcSEcCtD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000256	0.00861	CbGpPWpGaD
Clofazimine—Dizziness—Estradiol—osteoporosis	0.00025	0.00109	CcSEcCtD
Clofazimine—Vomiting—Estradiol—osteoporosis	0.00024	0.00104	CcSEcCtD
Clofazimine—Rash—Estradiol—osteoporosis	0.000238	0.00104	CcSEcCtD
Clofazimine—Dermatitis—Estradiol—osteoporosis	0.000238	0.00103	CcSEcCtD
Clofazimine—Headache—Estradiol—osteoporosis	0.000237	0.00103	CcSEcCtD
Clofazimine—Nausea—Estradiol—osteoporosis	0.000224	0.000975	CcSEcCtD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000218	0.00733	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000215	0.00725	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000215	0.00724	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00021	0.00707	CbGpPWpGaD
Clofazimine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000205	0.00691	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000204	0.00689	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000176	0.00594	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000163	0.00551	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000157	0.0053	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000141	0.00476	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000139	0.00468	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PKM—osteoporosis	0.000127	0.00427	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—FDPS—osteoporosis	0.000127	0.00427	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00012	0.00405	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PGLS—osteoporosis	0.00012	0.00405	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GPD2—osteoporosis	0.00012	0.00405	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000114	0.00385	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000114	0.00383	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000113	0.0038	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ATIC—osteoporosis	0.00011	0.0037	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PNP—osteoporosis	0.00011	0.0037	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	9.37e-05	0.00316	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—OXCT1—osteoporosis	9.34e-05	0.00315	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CA2—osteoporosis	9.34e-05	0.00315	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.27e-05	0.00312	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.24e-05	0.00311	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MGLL—osteoporosis	9.11e-05	0.00307	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.59e-05	0.00289	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.09e-05	0.00273	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—IDH2—osteoporosis	7.74e-05	0.00261	CbGpPWpGaD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	7.58e-05	0.00255	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP27A1—osteoporosis	7.28e-05	0.00245	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ACP5—osteoporosis	7.08e-05	0.00239	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.99e-05	0.00236	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.87e-05	0.00231	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL1B—osteoporosis	6.64e-05	0.00224	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—TPI1—osteoporosis	6.58e-05	0.00222	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.36e-05	0.00214	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—P4HB—osteoporosis	6.19e-05	0.00209	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GAPDH—osteoporosis	6.08e-05	0.00205	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—RAP1A—osteoporosis	5.92e-05	0.00199	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.57e-05	0.00188	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.16e-05	0.00174	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.16e-05	0.00174	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.92e-05	0.00166	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.91e-05	0.00165	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.86e-05	0.00164	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TNF—osteoporosis	4.82e-05	0.00162	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ENO1—osteoporosis	4.78e-05	0.00161	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PSMA5—osteoporosis	4.71e-05	0.00159	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PSMA2—osteoporosis	4.71e-05	0.00159	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PKM—osteoporosis	4.53e-05	0.00153	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—FDPS—osteoporosis	4.53e-05	0.00153	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GPD2—osteoporosis	4.29e-05	0.00145	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PGLS—osteoporosis	4.29e-05	0.00145	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.25e-05	0.00143	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ATIC—osteoporosis	3.93e-05	0.00132	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PNP—osteoporosis	3.93e-05	0.00132	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP19A1—osteoporosis	3.82e-05	0.00129	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CA2—osteoporosis	3.34e-05	0.00113	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—OXCT1—osteoporosis	3.34e-05	0.00113	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MGLL—osteoporosis	3.25e-05	0.0011	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ADCY5—osteoporosis	3.12e-05	0.00105	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GPX1—osteoporosis	3.11e-05	0.00105	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.96e-05	0.000997	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MTHFR—osteoporosis	2.87e-05	0.000968	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PKM—osteoporosis	2.79e-05	0.00094	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—FDPS—osteoporosis	2.79e-05	0.00094	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—IDH2—osteoporosis	2.77e-05	0.000932	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PGLS—osteoporosis	2.65e-05	0.000891	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GPD2—osteoporosis	2.65e-05	0.000891	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP27A1—osteoporosis	2.6e-05	0.000876	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.55e-05	0.00086	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.55e-05	0.000858	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ACP5—osteoporosis	2.53e-05	0.000853	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ATIC—osteoporosis	2.42e-05	0.000815	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PNP—osteoporosis	2.42e-05	0.000815	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.38e-05	0.000803	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.38e-05	0.000801	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—TPI1—osteoporosis	2.35e-05	0.000793	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—POMC—osteoporosis	2.3e-05	0.000774	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—P4HB—osteoporosis	2.21e-05	0.000745	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GAPDH—osteoporosis	2.17e-05	0.000732	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—RAP1A—osteoporosis	2.12e-05	0.000712	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.06e-05	0.000693	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CA2—osteoporosis	2.06e-05	0.000693	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MGLL—osteoporosis	2.01e-05	0.000675	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ENO1—osteoporosis	1.71e-05	0.000576	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—IDH2—osteoporosis	1.7e-05	0.000574	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PSMA2—osteoporosis	1.68e-05	0.000567	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PSMA5—osteoporosis	1.68e-05	0.000567	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.6e-05	0.00054	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ACP5—osteoporosis	1.56e-05	0.000525	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—TPI1—osteoporosis	1.45e-05	0.000488	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.37e-05	0.00046	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—P4HB—osteoporosis	1.36e-05	0.000459	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.34e-05	0.000451	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.3e-05	0.000439	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ADCY5—osteoporosis	1.12e-05	0.000376	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GPX1—osteoporosis	1.11e-05	0.000375	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ENO1—osteoporosis	1.05e-05	0.000355	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.04e-05	0.00035	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.04e-05	0.00035	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MTHFR—osteoporosis	1.03e-05	0.000346	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.42e-06	0.000284	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—POMC—osteoporosis	8.21e-06	0.000277	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.88e-06	0.000232	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GPX1—osteoporosis	6.86e-06	0.000231	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.33e-06	0.000213	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—POMC—osteoporosis	5.06e-06	0.00017	CbGpPWpGaD
